Comparative Effectiveness of Transurethral Prostate Procedures at Enabling Urologic Medication Discontinuation: a Retrospective Analysis.

  title={Comparative Effectiveness of Transurethral Prostate Procedures at Enabling Urologic Medication Discontinuation: a Retrospective Analysis.},
  author={N. Sabharwal and D. Shoskes and Elodi Dielubanza and J. Ulchaker and K. Fareed and B. Gill},
OBJECTIVES To test the hypothesis that transurethral prostate procedures (TUPPs) eliminating tissue result in greater medication discontinuation and lower de-novo initiation rates than procedures inducing tissue necrosis. METHODS Retrospective review of all men undergoing first time TUPPs at a large tertiary center from 2001-2016 was completed. Procedure type and urologic medication use before, 3-12 months after, and greater than 12 months after TUPP were analyzed with simple open… Expand
Medication Discontinuation Following Transurethral Prostatectomy: an Unrecognized Effectiveness Measure?
No recommendations or best practices inform the use of medical therapy following BPH surgery, and rates of BPH/LUTS medication use following transurethral prostatectomy are considerable. Expand
Persistent use of medical therapy after surgery for lower urinary tract symptoms: a retrospective database analysis
To determine how many men are able to remain off of medical therapy for lower urinary tract symptoms (LUTS) following surgery for benign prostatic obstruction (BPO). The TriNetX Analytics Network wasExpand
Anatomical endoscopic enucleation of the prostate: The next gold standard? No! (or not yet!)
It is believed aEEP is an important advance and a “practice‐changing” procedure that will play an important role in the BPH surgical options arsenal, especially for larger prostates, and in the future, EEP may be considered the gold‐standard treatment for BPH. Expand


Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement.
A meta-analysis demonstrates statistically comparable efficacy and overall morbidity for MISTs versus contemporary TURP and feels that the individual patient's clinical profile should be carefully assessed to identify the most appropriate transurethral technique. Expand
Transurethral Procedures for Lower Urinary Tract Symptoms Resulting From Benign Prostatic Enlargement: A Quality and Meta-Analysis
The selection of an appropriate surgical modality for BPH should be assessed by fully understanding each patient's clinical conditions, and there were no statistically significant differences in any of the modalities compared with TURP. Expand
Transurethral microwave therapy in 200 patients with a minimum followup of 2 years: urodynamic and clinical results.
Transurethral microwave therapy with second generation microwave equipment provides excellent long-term subjective and objective results in patients with a good initial response to treatment, and improved urinary flow, decreased post-void residual urine volume and urodynamic parameters remain stable at 2 years. Expand
A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update.
A meta-analysis of available randomized controlled trials shows that HoLEP is associated with more favorable outcomes than M-TURP in published RCTs and needs to be refined to propose tailored surgical treatment for benign prostatic obstruction relief. Expand
Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention.
TURP still represents the gold standard for managing benign prostatic hyperplasia with decreasing complication rates and technological improvements such as microprocessor-controlled units, better armamentarium such as video TUR, and training helped to reduce perioperative complications. Expand
Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
Despite documented safety and lack of morbidity, the high re-treatment rate associated with transUREthral needle ablation of the prostate renders it relatively expensive when viewed as a long-term alternative to transurethral resection of the prostatic hyperplasia in men in whom medical therapy failed. Expand
Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.
It is suggested that transurethral prostatectomy is less effective in overcoming urinary obstruction than the open operation, and the possibility that transUREthral prostatic hyperplasia may result in higher long-term mortality is raised. Expand
Recent advances in the surgical treatment of benign prostatic hyperplasia
Evaluated guidelines and higher evidence studies to evaluate the role of the most relevant new surgical approaches compared to TURP for the treatment of BPH and the most recent literature on this emerging field is evaluated. Expand
National Trends of Simple Prostatectomy for Benign Prostatic Hyperplasia With an Analysis of Risk Factors for Adverse Perioperative Outcomes.
The nationwide utilization of SP for BPH has decreased and older age, black race, and overall comorbidity were associated with greater risk of complications while the use of a minimally invasive approach and concurrent cystolithotomy had a decreased risk. Expand
Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study.
Open prostatectomy showed a satisfactory early postoperative outcome with a complication rate that was within the expected range compared to that in the recent literature. Expand